• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Friday, September 6, 2019

    Time

    10:30 AM - 12:00 PM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1.5 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $35.00

    • Overview

      The guidelines for treatment of elderly patients with diabetes is different from the treatment of the general population. Many healthcare professionals are not aware of ADA guidelines for diabetes treatment and the potential risk of conventional therapy in elderly patients with diabetes


      Handouts

      Slide Document 19100L01_6pp.pdf
      Slide Document 19100L01_2pp.pdf





      Financial Support By

      PharmCon
    • Pharmacist

      Identify American Diabetes Association (ADA) guidelines for treatment options in caring for older patients with diabetes.
      Recognize appropriate medication therapy for older patients with diabetes.
      Recognize potential drug interactions that may affect elderly patients with diabetes.
      Describe potential adverse effects of diabetes related medications.
      Identify barriers to compliance with diabetes therapy in elderly patients with diabetes.

      Pharmacy Technician

      Identify adverse effects of common diabetes medications.
      Recognize the connection between estimated glucose levels and hemoglobin A1c.
      Recognize the difference between basal and bolus insulin and implication on elderly patients with diabetes.
      Differentiate between the onset of action, peak effect and duration of action of different insulin products.

      Nurse

      Identify American Diabetes Association (ADA) guidelines for treatment options in caring for older patients with diabetes.
      Recognize appropriate medication therapy for older patients with diabetes.
      Recognize potential drug interactions that may affect elderly patients with diabetes.
      Describe potential adverse effects of diabetes related medications.
      Identify barriers to compliance with diabetes therapy in elderly patients with diabetes.
    • Repeat Presentation

      This presentation was last given on 1/2/2020 10:30 AM

      Future Airings

      Date Time
      Monday, October 28, 2019 10:30 AM View
      Thursday, January 2, 2020 10:30 AM View
      Friday, February 28, 2020 10:30 AM View

    • Activity Type

      Knowledge

      CE Broker

      20-657525

      Universal Activity Number

      Pharmacist 0798-0000-19-100-L01-P

      Pharmacy Technician 0798-0000-19-100-L01-T

      Nurse 0798-0000-19-100-L01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.